The risks of long-term and/or overuse of PPIs are further discussed in relation to the body system affected
10.1016/j.cmet.2020.04.001 71 LalauJ.-D.Al-SalamehA.HadjadjS.GoronflotT.WiernspergerN.PichelinM.et al (2021)
Key timing considerations: Side effect profile tends to be somewhat milder than semaglutide, which may reduce the importance of sleep-through timing Same 48-hour minimum spacing rule applies if changing injection days Pre-filled pen format means no reconstitution time, making spontaneous timing adjustments easier Many dulaglutide users report minimal side effects after the first month, at which point timing becomes purely a convenience decision Retatrutide (weekly injectable, investigational) Dosing frequency: Once weekly Half-life: Data from Phase 2 trials suggest approximately 6 days Peak concentration: Approximately 24 to 72 hours after injection Recommended timing approach: As a triple agonist (GLP-1/GIP/glucagon), retatrutide may produce a different side effect profile than pure GLP-1 or dual GLP-1/GIP agonists
The precise function of ferroptosis in the pathophysiology of OA is inadequately understood
For Singaporeans who find it challenging to lose weight through conventional methods, GLP-1 offers a new, medically-approved option for effective weight management
For example, Cigna suggests using a dedicated obesity management program as part of the medical benefit, alongside standard pharmacy benefit rules for the drugs
